These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Long-term outcomes of autologous stem cell transplantation for follicular non-Hodgkin lymphoma: effect of histological grade and Follicular International Prognostic Index. Vose JM; Bierman PJ; Loberiza FR; Lynch JC; Bociek GR; Weisenburger DD; Armitage JO Biol Blood Marrow Transplant; 2008 Jan; 14(1):36-42. PubMed ID: 18158959 [TBL] [Abstract][Full Text] [Related]
6. The role of hematopoietic stem cell transplantation in non-Hodgkin lymphoma. Villanueva ML; Vose JM Clin Adv Hematol Oncol; 2006 Jul; 4(7):521-30. PubMed ID: 17147239 [TBL] [Abstract][Full Text] [Related]
7. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue. Hagemeister FB Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984 [TBL] [Abstract][Full Text] [Related]
8. Tumor sclerosis but not cell proliferation or malignancy grade is a prognostic marker in advanced-stage follicular lymphoma: the German Low Grade Lymphoma Study Group. Klapper W; Hoster E; Rölver L; Schrader C; Janssen D; Tiemann M; Bernd HW; Determann O; Hansmann ML; Möller P; Feller A; Stein H; Wacker HH; Dreyling M; Unterhalt M; Hiddemann W; Ott G; J Clin Oncol; 2007 Aug; 25(22):3330-6. PubMed ID: 17664481 [TBL] [Abstract][Full Text] [Related]
9. Follicular lymphoma: a therapeutic update. Italiano A; Thyss A Bull Cancer; 2005 Oct; 92(10):E57-64. PubMed ID: 16266867 [TBL] [Abstract][Full Text] [Related]
10. [High-dose chemotherapy with autologous hematopoietic stem cell transplantation for non-Hodgkin's lymphoma in complete response as consolidation therapy, second report]. Yamane T; Hirose A; Nakajima Y; Nakane T; Koh H; Takeoka Y; Nakamae M; Yamamura R; Nakamae H; Nakao Y; Mugitani A; Yagi T; Teshima H; Hino M Gan To Kagaku Ryoho; 2006 Feb; 33(2):193-8. PubMed ID: 16484855 [TBL] [Abstract][Full Text] [Related]
11. A retrospective analysis of 144 patients with aggressive non-Hodgkin's lymphoma: impact of autologous stem cell transplantation in first remission on outcome. Fanin R; Sperotto A; Ruiz De Elvira C; Zaja F; Stocchi R; Geromin A; Cerno M; Patriarca F; Fanni Canelles M; Damiani D; Baccarani M Haematologica; 2000 Sep; 85(9):943-51. PubMed ID: 10980633 [TBL] [Abstract][Full Text] [Related]
12. High dose chemotherapy and autologous stem cell transplantation in patients with peripheral T-cell lymphoma not achieving complete response after induction chemotherapy. The GEL-TAMO experience. Rodriguez J; Caballero MD; Gutierrez A; Gandarillas M; Sierra J; Lopez-Guillermo A; Sureda A; Zuazu J; Marin J; Arranz R; Carreras E; Leon A; De Sevilla AF; San Miguel JF; Conde E; Haematologica; 2003 Dec; 88(12):1372-7. PubMed ID: 14687990 [TBL] [Abstract][Full Text] [Related]
13. Value of autologous stem cell transplantation with purged bone marrow as first-line therapy for follicular lymphoma with high tumor burden: a GOELAMS phase II study. Colombat P; Cornillet P; Deconinck E; Tourani JM; Gardembas M; Delain M; Abgrall JF; Kootz C; Milpied N Bone Marrow Transplant; 2000 Nov; 26(9):971-7. PubMed ID: 11100276 [TBL] [Abstract][Full Text] [Related]
14. Autologous stem cell transplantation in first-line treatment of high-risk aggressive non-Hodgkin's lymphoma. Vranovsky A; Ladicka M; Lakota J Neoplasma; 2008; 55(2):107-12. PubMed ID: 18652043 [TBL] [Abstract][Full Text] [Related]
15. Autologous stem cell transplantation in follicular non-Hodgkin's lymphoma. Pettengell R Bone Marrow Transplant; 2002 Feb; 29 Suppl 1():S1-4. PubMed ID: 11840153 [TBL] [Abstract][Full Text] [Related]
16. High-dose therapy combined with peripheral blood stem cell transplantation for advanced low-grade follicular lymphoma: single-institution experience in Japan. Fujimori Y; Saheki K; Yamada S; Yamada S; Mori A; Itoh T; Okada M; Takatsuka H; Wada H; Tamura S; Okamoto T; Takemoto Y; Kakishita E; Nagai K Int J Hematol; 1999 Oct; 70(3):207-8. PubMed ID: 10561916 [No Abstract] [Full Text] [Related]
17. Third biannual report of the Cochrane Haematological Malignancies Group. Kober T; Skoetz N; Trelle S; Bohlius J; Engert A; J Natl Cancer Inst; 2005 Aug; 97(16):E2. PubMed ID: 16106014 [No Abstract] [Full Text] [Related]
18. [Curative effect on aggressive B cell non-Hodgkin's lymphoma and relevant influencing factors of its prognosis, a study of 203 cases]. Xu RH; Jiang WQ; Li YH; Lin TY; Huang HQ; Xia ZJ; Sun XF; He YJ; Guan ZZ Zhonghua Yi Xue Za Zhi; 2003 Feb; 83(3):191-4. PubMed ID: 12812658 [TBL] [Abstract][Full Text] [Related]
19. [Autologous hematopoietic stem cell transplantation for aggressive B-cell non-Hodgkin's lymphoma]. Hirose A; Yamane T; Nakajima Y; Manabe M; Kanashima H; Hagihara K; Sakamoto E; Nakamae M; Terada Y; Kosaka S; Aoyama Y; Sakamoto C; Kumura T; Koh KR; Hirai M; Ohta K; Nakao Y; Mugitani A; Teshima H; Hino M Gan To Kagaku Ryoho; 2005 Dec; 32(13):2059-64. PubMed ID: 16352929 [TBL] [Abstract][Full Text] [Related]
20. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of diffuse large cell B-cell non-Hodgkin's lymphoma. Hahn T; Wolff SN; Czuczman M; Fisher RI; Lazarus HM; McCarthy PL; Vose J; Warren L; Watt R; Biol Blood Marrow Transplant; 2003 Oct; 9(10):667. PubMed ID: 14569563 [No Abstract] [Full Text] [Related] [Next] [New Search]